Tramontane Therapeutics creates solutions for common neurological and metabolic illnesses that affect a large number of patients. The company specializes in gene therapy, a cutting-edge approach that aims to treat diseases by modifying or replacing faulty genes. By leveraging this technology, Tramontane Therapeutics aims to address the significant unmet medical needs in the field of metabolic and neurodegenerative diseases. With a focus on developing effective treatments, the company aims to improve the lives of a large population of patients suffering from these conditions.